Capital expenditure · 2018–2025
Stoke Therapeutics capital expenditure
$670,000+230.0% · FY2025
Stoke Therapeutics (STOK) reported $670,000 in capital expenditure for fiscal 2025, +230.0% year on year.
| Fiscal year | Capital expenditure | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $670,000 | +230.0% | Open → |
| FY20242024-12-31 | $203,000 | −87.4% | Open → |
| FY20232023-12-31 | $1.6M | −59.2% | Open → |
| FY20222022-12-31 | $4.0M | +230.2% | Open → |
| FY20212021-12-31 | $1.2M | +14.3% | Open → |
| FY20202020-12-31 | $1.1M | −35.8% | Open → |
| FY20192019-12-31 | $1.6M | +74.9% | Open → |
| FY20182018-12-31 | $935,000 | — | Open → |
Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2018–2025 compound annual growth −4.6%
Capital expenditure at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Stoke Therapeutics capital expenditure |url=https://companiesranked.com/en/company/stoke-therapeutics/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Stoke Therapeutics capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/stoke-therapeutics/capital-expenditureBibTeX
@misc{companiesranked-en-company-stoke-therapeutics-capital-expenditure-2026,
author = {{CompaniesRanked}},
title = {{Stoke Therapeutics capital expenditure}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/stoke-therapeutics/capital-expenditure}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001193125-26-108362 · March 16, 2026
{{cite web |title=Stoke Therapeutics capital expenditure — 10-K (0001193125-26-108362) |url=https://www.sec.gov/Archives/edgar/data/1623526/000119312526108362/stok-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-03-16}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.